Literature DB >> 8163654

Intact human ceruloplasmin oxidatively modifies low density lipoprotein.

E Ehrenwald1, G M Chisolm, P L Fox.   

Abstract

Ceruloplasmin is a plasma protein that carries most of the copper found in the blood. Although its elevation after inflammation and trauma has led to its classification as an acute phase protein, its physiological role is uncertain. A frequently reported activity of ceruloplasmin is its ability to suppress oxidation of lipids. In light of the intense recent interest in the oxidation of plasma LDL, we investigated the effects of ceruloplasmin on the oxidation of this lipoprotein. In contrast to our expectations, highly purified, undegraded human ceruloplasmin enhanced rather than suppressed copper ion-mediated oxidation of LDL. Ceruloplasmin increased the oxidative modification of LDL as measured by thiobarbituric acid-reacting substances by at least 25-fold in 20 h, and increased electrophoretic mobility, conjugated dienes, and total lipid peroxides. In contrast, ceruloplasmin that was degraded to a complex containing 115- and 19-kD fragments inhibited cupric ion oxidation of LDL, as did commercial preparations, which were also degraded. However, the antioxidant capability of degraded ceruloplasmin in this system was similar to that of other proteins, including albumin. The copper in ceruloplasmin responsible for oxidant activity was not removed by ultrafiltration, indicating a tight association. Treatment of ceruloplasmin with Chelex-100 removed one of seven copper atoms per molecule and completely blocked oxidant activity. Restoration of the copper to ceruloplasmin also restored oxidant activity. These data indicate that ceruloplasmin, depending on the integrity of its structure and its bound copper, can exert a potent oxidant rather than antioxidant action on LDL. Our results invite speculation that ceruloplasmin may be in part responsible for oxidation of LDL in blood or in the arterial wall and may thus have a physiological role that is quite distinct from what is commonly believed.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1994        PMID: 8163654      PMCID: PMC294163          DOI: 10.1172/JCI117127

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  65 in total

1.  Inhibition by serum components of oxidation and collagen-binding of low-density lipoprotein.

Authors:  N Kalant; S McCormick
Journal:  Biochim Biophys Acta       Date:  1992-10-30

2.  Chemical evidence that proteolytic cleavage causes the heterogeneity present in human ceruloplasmin preparations.

Authors:  I B Kingston; B L Kingston; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity.

Authors:  F W Sunderman; S Nomoto
Journal:  Clin Chem       Date:  1970-11       Impact factor: 8.327

5.  The inhibition of lipid autoxidation by human serum and its relation to serum proteins and alpha-tocopherol.

Authors:  J Stocks; J M Gutteridge; R J Sharp; T L Dormandy
Journal:  Clin Sci Mol Med       Date:  1974-09

6.  Substrate activation and the kinetics of ferroxidase.

Authors:  C T Huber; E Frieden
Journal:  J Biol Chem       Date:  1970-08-10       Impact factor: 5.157

7.  Reinvestigation of some physicochemical and chemical properties of human ceruloplasmin (ferroxidase).

Authors:  L Rydén; I Björk
Journal:  Biochemistry       Date:  1976-08-10       Impact factor: 3.162

8.  The inhibition of lipid autoxidation by human caeruloplasmin.

Authors:  D J Al-Timimi; T L Dormandy
Journal:  Biochem J       Date:  1977-11-15       Impact factor: 3.857

9.  Continuous monitoring of in vitro oxidation of human low density lipoprotein.

Authors:  H Esterbauer; G Striegl; H Puhl; M Rotheneder
Journal:  Free Radic Res Commun       Date:  1989

10.  Determination of apoceruloplasmin by radioimmunoassay in nutritional copper deficiency, Menkes' kinky hair syndrome, Wilson's disease, and umbilical cord blood.

Authors:  I Matsuda; T Pearson; N A Holtzman
Journal:  Pediatr Res       Date:  1974-10       Impact factor: 3.756

View more
  31 in total

1.  Ceruloplasmin gene expression in the murine central nervous system.

Authors:  L W Klomp; Z S Farhangrazi; L L Dugan; J D Gitlin
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Identification of the prooxidant site of human ceruloplasmin: a model for oxidative damage by copper bound to protein surfaces.

Authors:  C K Mukhopadhyay; B Mazumder; P F Lindley; P L Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Experimental evidence for the cardioprotective effects of red wine.

Authors:  Samarjit Das; Dev D Santani; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2007

4.  Positive correlation of serum HDL cholesterol with blood mercury concentration in metabolic syndrome Korean men (analysis of KNANES 2008-2010, 2013).

Authors:  S J Park; K J Yeum; B Choi; Y S Kim; N S Joo
Journal:  J Endocrinol Invest       Date:  2016-04-23       Impact factor: 4.256

5.  Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells.

Authors:  E Ehrenwald; P L Fox
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

6.  Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta.

Authors:  A M Emsley; J Y Jeremy; G N Gomes; G D Angelini; F Plane
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

7.  Plasma ceruloplasmin, a regulator of nitric oxide activity, and incident cardiovascular risk in patients with CKD.

Authors:  David J Kennedy; Yiying Fan; Yuping Wu; Michael Pepoy; Stanley L Hazen; W H Wilson Tang
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 8.237

8.  Reduction of Cu(II) by lipid hydroperoxides: implications for the copper-dependent oxidation of low-density lipoprotein.

Authors:  R P Patel; D Svistunenko; M T Wilson; V M Darley-Usmar
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

Review 9.  Oxidized low-density lipoprotein.

Authors:  Sampath Parthasarathy; Achuthan Raghavamenon; Mahdi Omar Garelnabi; Nalini Santanam
Journal:  Methods Mol Biol       Date:  2010

10.  Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease?

Authors:  Ayşe Yeşim Göçmen; Emel Sahin; Ender Semiz; Saadet Gümuşlü
Journal:  Can J Cardiol       Date:  2008-03       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.